Ventilator-associated Pneumonia Clinical Trial
Official title:
Evaluating the Effectiveness of the Tongue Cleaner in Patients Wholly or Partially Dependent Care
The concern with oral infection and its systemic repercussions is old, many studies have
been undertaken to establish this relationship more precisely. One of the areas mouth still
little studied in this regard is the colonization of language within this universe of the
oral microbiota colonization and how this may affect the general state of health
care-dependent individuals.
This research aims to evaluate the efficiency of a tongue cleaning device and its potential
impacts on infectious patients fully or partially dependent care hospital.
Patients admitted to intensive care units and inpatient units will be evaluated, divided
into two groups: Study Group (SG) - Patients who receive oral hygiene using the tongue
cleaning device, and Control Group (CG) - Patients who are cared for according to the
routine of hospital nursing.
Patients admitted to intensive care units and inpatient units will be evaluated, divided
into two groups: Study Group (SG) - Patients who receive oral hygiene using the tongue
cleaning device, and Control Group (CG) - Patients who are cared for According to the
routine of hospital nursing.
The criteria for inclusion of elements of the research will follow the criteria of
dependence of patients on mechanical ventilation, if they are or not. Patients fully or
partially dependent care are patients who can not make your oral hygiene alone and dependent
on another individual to do so, if a hospital staff member health. Exclusion criteria will
be based on condition of dependency of the patient, intubation period under 48 hours and if
one refuses to participate in the research.
Patients will first be evaluated by a dentist, doctor and nursing, which together decide on
the inclusion of patients in the study based on the criterion of seriousness of the patient
by APACHE. The assessment will follow the clinical criterion of presence or absence of
tongue biofilm (Adachi 2005), and the collection swab with biofilm lingual to perform
culture and sensitivity. These assessments take place twice within five days, being held in
the first and fifth days. During this period the patients participating in the GE will
hygienic tongue using tongue cleaner (Tepe ®) and other standardized oral hygiene care by
the nursing team previously coached by dentist. CG patients receive the standard oral
hygiene care with a spatula and gauze soaked in mouthwash and tongue will not use the tongue
cleaner.
For the assessment of plaque and tongue of sample qualitative material for culture and
sensitivity attend three calibrated dentists.
For this study 25 patients will be assessed for EG and 25 for GC, a total of 50 patients
evaluated, and 100 samples of material collected.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01406951 -
Diagnostic Value of sTREM-1 and PCT Level as Well as CPIS Score for Ventilator-Associated Pneumonia Among ICU Sepsis Patients
|
N/A | |
Completed |
NCT00893763 -
Strategies To Prevent Pneumonia 2 (SToPP2)
|
Phase 2 | |
Recruiting |
NCT03581370 -
Short Infusion Versus Prolonged Infusion of Ceftolozane-tazobactam Among Patients With Ventilator Associated-pneumonia
|
Phase 3 | |
Completed |
NCT02070757 -
Safety and Efficacy Study of Ceftolozane/Tazobactam to Treat Ventilated Nosocomial Pneumonia (MK-7625A-008)
|
Phase 3 | |
Completed |
NCT03348579 -
Hospital-acquired Pneumonia in Intensive Care Unit
|
||
Completed |
NCT04242706 -
VITAL - VAP Prevention by BIP (Bactiguard Infection Protection) ETT Evac in Belgian ICUs
|
Phase 4 | |
Recruiting |
NCT05589727 -
Application of Ventilator-Associated Events (VAE) in Ventilator-Associated Pneumonia (VAP) Notified in Brazil
|
||
Not yet recruiting |
NCT06168734 -
Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
|
Phase 3 | |
Completed |
NCT02515448 -
A Pharmacokinetic-pharmacodynamic Dose Comparison Study of 8 mg/kg of Inhaled or Parenteral Gentamicin in 12 Mechanically Ventilated Critically Ill Patients Treated for Ventilator-associated Pneumonia
|
Phase 1 | |
Completed |
NCT01972425 -
Biomarker-based Exclusion of VAP for Improved Antibiotic Stewardship
|
N/A | |
Completed |
NCT02838160 -
Effectiveness of Different Educational Strategies on the KAP, Psychological and Clinical Outcomes
|
N/A | |
Completed |
NCT01467648 -
The Pharmacodynamics of Doripenem Between 4-hour and 1-hour Infusion in Patients With Ventilator-associated Pneumonia
|
Phase 4 | |
Completed |
NCT00364299 -
Prevention of Ventilator-Associated Pneumonia by Automatic Control of the Tracheal Tube Cuff Pressure
|
N/A | |
Not yet recruiting |
NCT03018431 -
CT Scan and Lung Ultrasonography to Improve Diagnostic of Ventilation Acquired Pneumonia in ICU
|
N/A | |
Completed |
NCT02515617 -
Medico-economic Study of the Subglottic Secretions Drainage in Prevention of Ventilator-associated Pneumonia (DEMETER)
|
N/A | |
Completed |
NCT02583308 -
Impact of the Subglottic Secretions Drainage on the Tracheal Secretions Colonisation
|
N/A | |
Completed |
NCT02585180 -
Subglottic Secretions Surveillance to Predict Bacterial Pathogens Involved in Ventilator-associated Pneumonia
|
N/A | |
Recruiting |
NCT01546974 -
Ventilator-associated Pneumonia (VAP) and Humidification System
|
Phase 4 | |
Completed |
NCT02060045 -
Prevention Ventilator Associated Pneumonia
|
N/A | |
Terminated |
NCT00543608 -
Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia
|
Phase 2 |